Disease Indications Articles
The U.S. Food and Drug Administration has approved two treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years and older.
The U.S. Food and Drug Administration has approved Bristol Myers Squibb’s repotrectinib (Augtryo) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
The U.S. Food and Drug Admini-stration has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara, for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older.
Researchers at the University of California, San Francisco, have identified a specific pattern of autoantibodies in the blood that precedes the clinical onset of multiple sclerosis.
The U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for Octapharma’s wilate, von Willebrand factor/coagulation factor VIII complex (human) lyophilized powder for solution for intravenous injection, for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children 6 years of age and older with von Willebrand disease (VWD).
Post-pandemic America is facing a mental health crisis, but collaboration and creativity in healthcare aim to improve the nation’s mental wellness.
Sleep disorders are responsible for a host of physical and mental health conditions, making it essential to dispel the myths surrounding them and to promote education and awareness about the importance of sleep health.
While malaria is no longer endemic in the United States, the mosquito-borne disease can still affect those who live in or travel to tropical areas of the globe.
Though mostly benign, this bothersome skin disease could be dangerous for those with a compromised immune system. But while an effective, FDA-approved treatment specially formulated for the highly contagious poxvirus has eluded the disease — that's no longer the case.
OCD is no joke, and the rash of hurtful memes about the condition minimize the amount of suffering that people with OCD live through on a daily basis. But perhaps by understanding OCD, how it affects those who suffer from it and how it is treated, the ignorant, albeit mostly innocent, statements such as “I’m so OCD!” will cease.
An unusual uptick in pediatric hepatitis recently put the medical community on edge. Here's what we know, why it matters and what to do to mitigate the condition going forward.
The mystery behind the sudden outbreak of acute severe hepatitis in 2022 is revealed.
